A Phase I, multicenter, single-arm study to evaluate the pharmacokinetics, pharmacodynamics, and safety of crovalimab in patients with lupus nephritis
Autoimmune Disorder Lupus Nephritis
For the latest version of this information please go to www.forpatients.roche.com